LncRNA PSMB8-AS1通过miR-382-3p/BCAT1轴增加质瘤恶性
Haibo Liu1, Jie Zhang2, Jiamin Li3
1Department of Neurosurgery, Pengzhou People's Hospital, Chengdu 610500, Sichuan, China; Department of Neurosurgery, Pengzhou Second People's Hospital, Chengdu 610500, Sichuan, China; Department of Neurosurgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, Sichuan, China.
Translational oncology
|January 18, 2024
概括
长非编码RNAPSMB8-AS1通过通过海绵化miR-382-3p增强BCAT1促进结质瘤. 这种lncRNAPSMB8-AS1可能成为质瘤治疗的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 质瘤是具有复杂分子基础的原发性脑瘤.
- 长非编码RNAs (lncRNAs) 在瘤发生中起着关键作用.
- 在质瘤中,lncRNA PSMB8-AS1/miR-382-3p/BCAT1轴的特定功能仍然在很大程度上未被探索.
研究的目的:
- 为了阐明lncRNA蛋白酶体20S子单元β8 (PSMB8) -抗义RNA1 (AS1) /microRNA (miR) -382-3p/分支链氨基酸转氨酶1 (BCAT1) 相互作用网络在质瘤中的作用.
- 研究 lncRNA PSMB8-AS1 作为质瘤治疗点的潜力.
主要方法:
- 定量逆转录-聚合酶连锁反应和西式涂抹来评估表达水平.
- 细胞增殖,迁移和亡测定 (CCK-8,Transwell,caspase-3活动).
- 在体内异种移植小鼠模型和双路西法酶/RNA免疫沉试验以确认分子相互作用.
主要成果:
- lncRNA PSMB8-AS1和BCAT1过度表达,而miR-382-3p在质瘤组织和细胞系中表达不足.
- 通过PSMB8-AS1敲击,抑制了结质瘤细胞的增殖和迁移,同时在体外和体内促进了细胞亡.
- PSMB8-AS1作为miR-382-3p的海绵,导致BCAT1的表达增加,从而促进质瘤恶性.
结论:
- lncRNA PSMB8-AS1通过通过海绵化miR-382-3p对BCAT1进行上调来促进质瘤的进展.
- lncRNA PSMB8-AS1 代表了潜在的诊断生物标志物和质瘤的治疗点.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


